| Issue Date |
Title |
Author(s) |
| Jan-2021 |
Both the subtypes of KIT mutation and minimal residual disease are associated with prognosis in core binding factor acute myeloid leukemia: a retrospective clinical cohort study in single center |
Duan, Wenbing;Liu, Xiaohong;Zhao, Xiaosu;Jia, Jinsong;Wang, Jing;Gong, Lizhong;Jiang, Qian;Zhao, Ting;Wang, Yu;Zhang, Xiaohui;Xu, Lanping;Shi, Hongxia;Chang, Yingjun;Liu, Kaiyan;Huang, Xiaojun;Qin, Yazhen;Jiang, Hao |
| 23-Nov-2021 |
A Clinical Study of 15 Acute Leukemia Patients with Plasmacytoid Dendritic Cells Expansion |
Zhou, Ya-Lan;Wei, Yan;Liu, Xiaohong;Wang, Jing;Jia, Jinsong;Shi, Hong-Xia;Chang, Ying-Jun;Zhao, Xiao-Su;Liu, Yan-Rong;Ruan, Guo-Rui;Huang, Xiao-Jun;Jiang, Hao |
| 15-Nov-2022 |
Interferon-alpha-2b As a Maintenance Therapy Gain a High Rate of MRD Negative Conversion and Improve RFS in Patients with Favorable-Risk Acute Myeloid Leukemia-a Prospective, Single-Arm Study |
Liu, Xiaohong;Li, Yao;Yu, Wenjing;Zhu, Xiaolu;Jia, Jinsong;Gong, Lizhong;Zhao, Xiaosu;Chang, Yingjun;Huang, Xiao-Jun;Jiang, Hao |
| Jan-2021 |
The loss or absence of minimal residual disease of <0 center dot 1% at any time after two cycles of consolidation chemotherapy in CBFB-MYH11-positive acute myeloid leukaemia indicates poor prognosis |
Duan, Wenbing;Liu, Xiaohong;Jia, Jinsong;Wang, Jing;Gong, Lizhong;Jiang, Qian;Zhao, Ting;Wang, Yu;Zhang, Xiaohui;Xu, Lanping;Zhao, Xiaosu;Qin, Yazhen;Shi, Hongxia;Chang, Yingjun;Huang, Xiaojun;Jiang, Hao |
| 23-Nov-2021 |
Predictors of Efficacy in Chinese Patients with Severe Aplastic Anemia Treated with Eltrombopag and Intensive Immunosupressive Therapy |
Li, Ruixin;He, Guangsheng;Chen, Xi;Liu, Zhengyuan;Yang, Yan;Lin, Shengyun;Jia, Jinsong;Jin, Yuanyuan;Long, Qiqiang;Liu, Xiaoqing;Cheng, Lang;Zhou, Jiongtao;Li, Jianyong |
| Jan-2023 |
Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world |
Li, Ruixin;Wang, Ningling;Chai, Xingxing;Yang, Linhai;Liu, Kangkang;He, Hailong;Lin, Shengyun;Yang, Yan;Jia, Jinsong;Zhang, Donghua;Gong, Yuemin;Shi, Jinning;He, Guangsheng;Li, Jianyong |
| 15-Nov-2022 |
Prolonged Use of Eltrombopag in Patients with Severe Aplastic Anemia without Complete Response at 6 Months after Immunosuppressive Therapy |
Li, Ruixin;Long, Qiqiang;Yang, Yan;Lin, Shengyun;Jia, Jinsong;Zhang, Donghua;He, Guangsheng;Li, Jianyong |
| Jan-2023 |
A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia (vol 101, pg 2413, 2022) |
Jin, Yuanyuan;Li, Ruixin;Lin, Shengyun;Jia, Jinsong;Yang, Yan;Zhang, Donghua;He, Guangsheng;Li, Jiangyong |
| 23-Nov-2021 |
Safety and Short-Term Efficacy of Venetoclax Combined with Azacitidine in Acute Myeloid Leukemia: A Single Institution Experience |
Yu, Wen-Jing;Jia, Jinsong;Wang, Jing;Tang, Fei-Fei;Gong, Lizhong;Liu, Xiaohong;Zhu, Xiaolu;Zhao, Xiaosu;Huang, Xiao Jun;Jiang, Hao |
